We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock
VINC

Delisted

VINC was delisted on the 22nd of April, 2025.

Back to rankings

56 hedge funds and large institutions have $157M invested in Vincerx Pharma, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 6

150% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 8

56% more funds holding

Funds holding: 36 → 56 (+20)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

8% less capital invested

Capital invested by funds: $171M → $157M (-$13.8M)

Holders
56
Holders Change
+20
Holders Change %
+55.56%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
20
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$8.13M
2
TCM
Tang Capital Management
California
+$8.08M
3
BC
Boxer Capital
California
+$6.85M
4
AAA
Affinity Asset Advisors
New York
+$4.5M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.85M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$9.26M
2
PA
Perceptive Advisors
New York
-$5.79M
3
PI
Putnam Investments
Massachusetts
-$4.25M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$973K
5
MIM
Monashee Investment Management
Massachusetts
-$776K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$898K +$1.05M +3,455 New
Northern Trust
27
Northern Trust
Illinois
$834K +$703K +2,308 +257%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$775K +$910K +2,987 New
BFM
29
Boothbay Fund Management
New York
$705K +$127K +416 +18%
Millennium Management
30
Millennium Management
New York
$663K -$413K -1,355 -35%
MIM
31
Monashee Investment Management
Massachusetts
$637K -$776K -2,547 -51%
Marshall Wace
32
Marshall Wace
United Kingdom
$628K +$737K +2,418 New
Creative Planning
33
Creative Planning
Kansas
$455K +$533K +1,750 New
Morgan Stanley
34
Morgan Stanley
New York
$419K +$315K +1,033 +177%
V
35
Veritable
Delaware
$378K +$443K +1,454 New
M
36
Murchinson
Ontario, Canada
$377K +$442K +1,452 New
Two Sigma Investments
37
Two Sigma Investments
New York
$309K +$363K +1,191 New
JF
38
Jump Financial
Illinois
$260K +$305K +1,000 New
Charles Schwab
39
Charles Schwab
California
$224K +$262K +860 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$156K +$183K +601 New
SC
41
Shay Capital
New York
$148K +$173K +568 New
PNC Financial Services Group
42
PNC Financial Services Group
Pennsylvania
$130K – – –
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$116K +$136K +445 New
Bank of America
44
Bank of America
North Carolina
$114K +$131K +429 +4,767%
JP Morgan Chase
45
JP Morgan Chase
New York
$91K +$107K +352 New
Wells Fargo
46
Wells Fargo
California
$84K +$41.7K +137 +73%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$84K +$98.1K +322 New
PCM
48
Penserra Capital Management
California
$43K -$6.09K -20 -11%
Deutsche Bank
49
Deutsche Bank
Germany
$36K +$42.7K +140 New
SO
50
STRS Ohio
Ohio
$14K +$16.8K +55 New
1
2
3

VINC Hedge Fund Activity: Q2 2021 in Review

56 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Common Stock (VINC) for Q2 2021, worth a combined $157M — down 8.1% from $171M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new VINC positions and 6 closed out — a net gain of 20 holders — while 20 added to existing stakes and 8 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $8.13M. The largest seller was Logos Global Management, exiting entirely with an estimated $9.26M sold.

  • 56 institutional investors held Vincerx Pharma, Inc. Common Stock (VINC) as of Q2 2021, up from 36 in Q1 2021.
  • Funds reported $157M of Vincerx Pharma, Inc. Common Stock stock for Q2 2021, down 8.1% quarter-over-quarter.
  • 26 funds opened new Vincerx Pharma, Inc. Common Stock positions in Q2 2021 and 6 closed out, a net change of +20 holders.
  • The largest Vincerx Pharma, Inc. Common Stock buyer in Q2 2021 was Rubric Capital Management (New York), an estimated $8.13M added.
  • The largest Vincerx Pharma, Inc. Common Stock seller in Q2 2021 was Logos Global Management, an estimated $9.26M sold.

Based on aggregated 13F filings for Q2 2021.